Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The New England Journal of Medicine|May 23, 2014
Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetesJessica S Albert, Laura M Yerges-Armstrong, Richard B Horenstein, et al.
The Pharmacogenomics Journal|September 22, 2018
Genome-wide association analysis of common genetic variants of resistant hypertensionNihal El Rouby, Caitrin W McDonough, Yan Gong, et al.
Archives of Internal Medicine|November 10, 2010
Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amishHaiqing Shen, Coleen M Damcott, Evadnie Rampersaud, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics ProgramAlan R Shuldiner, Kathleen Palmer, Ruth E Pakyz, et al.
Circulation. Cardiovascular Genetics|February 9, 2013
Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomesJoshua P Lewis, Kathleen Ryan, Jeffrey R O'Connell, et al.
American Heart Journal|April 29, 2008
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart StudyBraxton D Mitchell, Patrick F McArdle, Haiqing Shen, et al.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Pageof 3